A young patient with multiple myeloma

Slides:



Advertisements
Similar presentations
MGUS (interpreting the test you didnt order) Family Medicine Review Course 2011 Christian Cable, MD, FACP.
Advertisements

Multiple Myeloma Serena Ezzeddine Morning Report May 30, 2009.
Show and Tell FIRM B - RED. Our team Dr. Clarke & Dr. Vargas Shinoj & Arvind Jacob & Muneeza Chloe, Lauren & Njiye.
PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS)  Idiopathic  Associated with other diseases (autoimmune, infectious, non-heme.
Staff Oncologist, Mayo Clinic Arizona
Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification: Implications.
Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological.
H Nèji, H Abid, A Mâalej, S Haddar, R Akrout*, M Ezzeddine*, S Baklouti*, Z Mnif**, J Mnif Imaging department Habib Bourguiba Hospital, *Rheumatology department.
MULTIPLE MYELOMA (MM).
Thalidomide, Radiation, and Peripheral Stem Cell Transplantation as Combination Treatment for Multiple Myeloma Allison Reczek Department of Biological.
NYU Medical Grand Rounds Clinical Vignette Ankit Parikh MD, PGY-2 January 6, 2009 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Understanding Your Blood Work
Cancer Among Native Americans in Arizona and New Mexico Data Provided by Arizona Cancer Registry at the Arizona Department of Health Services and the New.
Multiple Myeloma Definition:
Clinical interpretation of Serum Free Light Chain assays 22 Feb 2013 Dr. Eric Chan Consultant Immunologist Queen Mary Hospital Hong Kong.
Multiple Myeloma Presented by: Mike Lynch Mike Lynch.
Plasma cell disorders Dr. hassanali vahedian ardakani Medical oncologist hematologist 2013.
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein)
Plasma cell Disorders S. Sami Kartı, MD, Prof.. Plasma cells  Terminally differentiated cells of B- lymphocyte lineage  Produce antibodies  Normal.
Multiple Myeloma Definition:
The Importance of Survivorship in Multiple Myeloma.
Awareness Is Everything By Karis M. Blalock. Hypothesis Why is it important to understand what Multiple Myeloma is?
Marisiensis 2015 University of Medicine and Pharmacy Tîrgu-Mure The treatment of multiple myeloma using Bortezomib (Velcade™) Author: Stanca Mihai Coauthors:
CASE 5 56 yr-old man HIV Asymptomatic CD4 840 HIV viral load
Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney Sophina Hissaund FY2.
Multiple Myeloma Morning Report July 21, 2009 Lindsay Kruska.
Justin A. Crocker.  1 of the monoclonal gammopathies  Neoplastic proliferation of immunoglobulin producing plasma cells (single clone), often resulting.
Plasma cell dyscrasias. Multiple Myeloma By Dr. Muna A. Kashmool.
Jesse C James MD AM Report May 7,  Proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein  Malignant.
HEMATOPATHOLOGY MODULE Prepared by Emmanuel R. de la Fuente, M.D.
Robert Z. Orlowski, MD, PhD Associate Professor of Lymphoma/Myeloma and of Experimental Therapeutics Division of Cancer Medicine Director, Myeloma Section.
상복부 통증을 주소로 내원한 46 세 여자 환 자 연세대학교 원주의과대학 원주기독병원 소화기내과, 1 병리과 석기태, 김재우, 조미연 1, 김현수.
M. Multiple Myeloma Malignant proliferation of plasma cells. Malignant proliferation of plasma cells. Normal plasma cell form Ig which contain heavy and.
Multiple Myeloma March 13, 2012 Suzanne R. Fanning, DO Greenville Health System.
Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College
Multiple Myeloma: Is it now a curable disease?
Case Study Multiple Myeloma.
Myeloma hope new treatment in the horizon
R1.이용석 / modulator pf.한재준.
MLAB Hematology Keri Brophy-Martinez
Dr WAQAR ASST. PROFESSOR INTERNAL MEDICINE
MLAB Hematology Fall 2007 Keri Brophy-Martinez
Diagnosis of Solitary Plasmocytoma
MBL: mostly benign lymphocytes, but…
by Christopher Dittus, and Dana Semmel
by Michele Paessler, and John Choi
Anaplastic variant of plasma cell myeloma with Dutcher bodies
CNS involvement in DLBCL
Multiple Myeloma: Diagnosis and Treatment
The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Multiple Myeloma  Mehdi Hamadani, Erinn Hade, Don M. Benson,
by Qin Huang Blood Volume 122(1):6-6 July 4, 2013
by Elham Kamangar, and Weiqiang Zhao
Parasternal mass Blood Volume 113(6): February 5, 2009
by Yahya Daneshbod, and Tayebe Kazemi
Metastatic epithelioid angiosarcoma with bone marrow involvement
Solitary plasmacytoma of bone and asymptomatic multiple myeloma
Rare and strange invader
Relapsed lymphoma preceded by cold agglutinin disease
Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature.
Hyperviscosity syndrome
by Toru Takahashi, and Masafumi Matsuguma
Erythroid karyorrhexis in myelodysplasia: bone marrow aspirate
Erythroid leukemia evolving from multiple myeloma
Multiple Myeloma in Serologic Complete Remission after Autologous Stem Cell Transplantation: Impact of Bone Marrow Plasma Cell Assessment by Conventional.
PARAPRTEINAEMIA and MULTIPLE MYELOMA
Red Blood Cell Disorders
How I vaccinate blood and marrow transplant recipients
Metastatic malignant melanoma in the bone marrow
Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined significance. #Mayo Clinic Risk.
Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma  Luciano J. Costa, Jia-Xing Huang, Parameswaran.
Presentation transcript:

A young patient with multiple myeloma by Javier Munoz, and Amr Hanbali Blood Volume 119(13):2979-2979 March 29, 2012 ©2012 by American Society of Hematology

A 23-year-old female presented with progressive low back pain for several weeks. A 23-year-old female presented with progressive low back pain for several weeks. She had been diagnosed with dermatomyositis at the age of 3 and received corticosteroids episodically for 5 years until her rheumatologic condition achieved complete remission. Magnetic resonance imaging of the spine showed a T2 bright lesion (panel A) at multiple levels without evidence of cord compression. Laboratory findings included normocytic anemia of 9.2 g/dL, normal platelets and white blood cell count, β-2 microglobulin of 3.3 mg/L, normal calcium and creatinine. Serum electrophoresis revealed high levels of serum IgG (7970 mg/dL) characterized as IgG κ monoclonal protein. Urine protein electrophoresis showed 7.6 mg/dL of IgG κ monoclonal protein. Bone marrow biopsy and aspirate (panel B) showed a hypercellular marrow with 43% infiltration of plasma cells. A diagnosis of IgG κ multiple myeloma was made and treatment was started with lenalidomide, bortezomib, and dexamethasone. An autologous bone marrow transplantation is planned. This case highlights the value of clinical assessment. Multiple myeloma is infrequently seen in patients under the age of 30 and dermatomyositis is a disease known to be associated with malignancies. Few cases reported in the literature describe paraneoplastic dermatomyositis associated with pre-existent multiple myeloma. This very young patient developed multiple myeloma associated with pre-existent dermatomyositis. The precise relationship between dermatomyositis and myeloma is unknown. Javier Munoz, and Amr Hanbali Blood 2012;119:2979 ©2012 by American Society of Hematology